The prevalence and risk factors for gallstone disease

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 7, 2009, Pages 795-807

  Yoo, Eun Hyung ^a   Lee, Soo Youn ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bile; Cholelithiasis; Gallbladder; Gallstone; Prevalence

Indexed keywords

CHOLELITHIASIS; ENVIRONMENTAL FACTOR; GALLSTONE FORMATION; HEREDITY; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGE FACTORS; GALLSTONES; HORMONES; HUMANS; METABOLIC DISEASES; PREVALENCE; RISK FACTORS;

EID: 67849127027     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.194     Document Type: Review

References (233)

1. Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Gallstone disease. Br Med J 2001;322: 91-4.
2. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (MICOL). Am J Epidemiol 1995;141:158- 65.
3. Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM. Symptomatic and silent gall stones in the community. Gut 1991;32:316-20.
4. Friedman GD, Raviola CA, Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989;42:127-36.
5. Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg 1993;165:399-404.
6. Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg 2004;91:734-8.
7. Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995;21:655-60.
8. A prospective analysis of 1518 laparoscopic cholecystec- tomies. The Southern Surgeons Club. N Engl J Med 1991;324:1073-8.
9. Shea JA, Healey MJ, Berlin JA, Clarke JR, Malet PF, Sta- roscik RN, et al. Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis. Ann Surg 1996;224:609-20.
10. National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg 1993;165:390-8.
11. Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005;2:423-33.
12. Lammert F, Neubrand MW, Bittner R, Feussner H, Grei- ner L, Hagenmuller F, et al. [S3-guidelines for diagnosis and treatment of gallstones. German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract]. Z Gastroenterol 2007;45:971-1001.
13. Perez-Ayuso RM, Hernandez V, Gonzalez B, Carvacho C, Navarrete C, Alvarez M, et al. [Natural history of cholelithiasis and incidence of cholecystectomy in an urban and a Mapuche rural area]. Rev Med Chil 2002;130:723-30.
14. Dutta U, Nagi B, Garg PK, Sinha SK, Singh K, Tandon RK. Patients with gallstones develop gallbladder cancer at an earlier age. Eur J Cancer Prev 2005;14:381-5.
15. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-76.
16. Kar P, Kumar R, Kapur BM, Tandon BN, Tandon RK. Surgical obstructive jaundice in India: a clinical profile. J Assoc Physicians India 1986;34:115-8.
17. Nilsell K, Angelin B, Liljeqvist L, Einarsson K. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology 1985; 89:287-93.
18. LaMont JT, Smith BF, Moore JR. Role of gallbladder mucin in pathophysiology of gallstones. Hepatology 1984;4:51S-6S.
19. Wang HH, Afdhal NH, Gendler SJ, Wang DQ. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroen- terology 2006;131:210-22.
20. Corradini SG, Liguori F. [Recent studies on the patho- genesis of cholelithiasis: the role of the gallbladder epithelium]. Recenti Prog Med 2001;92:471-6.
21. The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology 1988;8:904-6.
22. Barbara L, Sama C, Morselli Labate AM, Taroni F, Rus- ticali AG, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987;7:913-7.
23. Glambek I, Kvaale G, Arnesjo B, Soreide O. Prevalence of gallstones in a Norwegian population. Scand J Gas- troenterol 1987;22:1089-94.
24. Thijs C, Knipschild P, van Engelshoven J. The prevalence of gallstone disease in a Dutch population. Scand J Gastroenterol 1990;25:155-60.
25. Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol 1987;126:912-21.
26. Loria P, Dilengite MA, Bozzoli M, Carubbi F, Messora R, Sassatelli R, et al. Prevalence rates of gallstone disease in Italy. The Chianciano population study. Eur J Epidemiol 1994;10:143-50.
27. Khuroo MS, Mahajan R, Zargar SA, Javid G, Sapru S. Prevalence of biliary tract disease in India: a sonographic study in adult population in Kashmir. Gut 1989;30:201-5.
28. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990; 131:836-44.
29. Maurer KR, Everhart JE, Ezzati TM, Johannes RS, Know- ler WC, Larson DL, et al. Prevalence of gallstone disease in Hispanic populations in the United States. Gastroen- terology 1989;96:487-92.
30. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Ike- matsu H, Noguchi A, et al. Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol 1988;128:598-605.
31. Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005;71:97-105.
32. Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999;27:1-7.
33. Bagi Abdel M, Arabi M, Abdel Rahim B, Al Asma A, Gibril M, Mubarak M, et al. Prevalence of gallbladder disease in Sudan: first sonographic field study in adult population [abstract]. Gastroenterology 1991;100:A307.
34. Walker AR, Segal I, Posner R, Shein H, Tsotetsi NG, Walker AJ. Prevalence of gallstones in elderly black women in Soweto, Johannesburg, as assessed by ultrasound. Am J Gastroenterol 1989;84:1383-5.
35. Safer L, Bdioui F, Braham A, Ben Salem K, Soltani MS, Bchir A, et al. [Epidemiology of cholelithiasis in central Tunisia. Prevalence and associated factors in a non- selected population]. Gastroenterol Clin Biol 2000;24: 883-7.
36. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117:632-9.
37. Moro PL, Checkley W, Gilman RH, Cabrera L, Lescano AG, Bonilla JJ, et al. Gallstone disease in Peruvian coastal natives and highland migrants. Gut 2000;46:569-73.
38. Covarrubias C, Miquel J, Puglieli L, Hofmann E, Gian- caspero R, Ebensberger E, et al. The role of ethnicity and other risk factors for cholelithiasis in a highly prevalent area: cross-sectional and cohort studies in chileans and amerindian araucanos. Gastroenterology 1995;108: A1053.
39. Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemio- logical survey. J Gastroenterol Hepatol 2006;21:1737-43.
40. Zhao Y, Zhang R, Hu Y, Li R, Liang L, Gang Y. [An epi- demiological survey of gallstones with gray-scale ultrasound]. Hua Xi Yi Ke Da Xue Xue Bao 1990;21:217-20.
41. Chung YJ, Park YD, Jeon SW, Cho CM, TakWY, Kweon YO, et al. Prevalence and risk factors of gallstones in a general health screened population. Korean J Med 2007;73:480-90.
42. Abu-Eshy SA, Mahfouz AA, Badr A, El Gamal MN, Al- Shehri MY, Salati MI, et al. Prevalence and risk factors of gallstone disease in a high altitude Saudi population. East Mediterr Health J 2007;13:794-802.
43. Kratzer W, Kachele V, Mason RA, Hill V, Hay B, Haug C, et al. Gallstone prevalence in Germany: the Ulm Gallbladder Stone Study. Dig Dis Sci 1998;43:1285-91.
44. Reshetnikov OV, Ryabikov AN, Shakhmatov SG, Malyu- tina SK. Gallstone disease prevalence in Western Siberia: cross-sectional ultrasound study versus autopsy. J Gastroenterol Hepatol 2002;17:702-7.
45. Caroli-Bosc FX, Deveau C, Harris A, Delabre B, Peten EP, Hastier P, et al. Prevalence of cholelithiasis: results of an epidemiologic investigation in Vidauban, southeast France. General Practitioner's Group of Vidauban. Dig Dis Sci 1999;44:1322-9.
46. Martinez de Pancorbo C, Carballo F, Horcajo P, Aldeguer M, de la Villa I, Nieto E, et al. Prevalence and associated factors for gallstone disease: results of a population survey in Spain. J Clin Epidemiol 1997;50:1347-55.
47. Prevalence of gallstone disease in an Italian adult female population. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Am J Epidemiol 1984;119:796-805.
48. Tomecki R, Dzieniszewski J, Gerke W, Kalina Z, Marlicz K, Maliszewska E, et al. [Cholecystolithiasis in the urban population of Poland]. Pol Arch MedWewn 1995;94:243-9.
49. Diehl AK, Stern MP. Special health problems of Mexican- Americans: obesity, gallbladder disease, diabetes melli- tus, and cardiovascular disease. Adv Intern Med 1989; 34:73-96.
50. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA. Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 1970;283:1358-64.
51. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002;35:1507-12.
52. Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J 2001;77:221-9.
53. Moro PL, Checkley W, Gilman RH, Lescano G, Bonilla JJ, Silva B, et al. Gallstone disease in high-altitude Peruvian rural populations. Am J Gastroenterol 1999;94:153-8.
54. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-9.
55. Jung HW, Kim YS, Chun KS, Kim MW, Choi HY. Prevalence of gallstones in Korea. J Korean Acad Fam Med 1992;13:581-91.
56. Lee SY, Lee SK, Kim JW, Han DS, Kim MH, Min YI, et al. Clinical study on gallstone prevalence in general health screening people. Korean J Intern Med 1994;47:352-8.
57. Park YH, Park SJ, Jang JY, Ahn YJ, Park YC, Yoon YB, et al. Changing patterns of gallstone disease in Korea. World J Surg 2004;28:206-10.
58. Lu SN, Chang WY, Wang LY, Hsieh MY, Chuang WL, Chen SC, et al. Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol 1990;12:542-6.
59. Lai SW, Ng KC. Risk factors for gallstone disease in a hospital-based study. South Med J 2002;95:1419-23.
60. Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, et al. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 1998;27:437-41.
61. Tazuma S. Gallstone disease: epidemiology, pathogen- esis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol 2006;20:1075-83.
62. Nakayama F, Miyake H. Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition. Am J Surg 1970;120:794-9.
63. Su CH, Lui WY, P'Eng FK. Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci 1992;37:764-8.
64. Park SJ, Kim SW, Park YC, Kim YT, Yun YB, Park YH. [Clinical and epidemiological analysis of a 20-year experience of surgically treated gallstone patients]. Korean J Gastroenterol 2003;42:415-22.
65. Yang SH, Lee SE, Jang JY, Ryu JK, Kim YT, Yun YB, et al. [Clinical and epidemiological analysis of gallstone patients focused on 25-year experience of surgically treated patients]. Korean J Gastroenterol 2007;50:42-50.
66. Kim MH, Sekijima J, Park HZ, Lee SP. Structure and composition of primary intrahepatic stones in Korean patients. Dig Dis Sci 1995;40:2143-51.
67. Nagase M, Hikasa Y, Soloway RD, Tanimura H, Setoya- ma M, Kato H. Gallstones in Western Japan. Factors affecting the prevalence of intrahepatic gallstones. Gas- troenterology 1980;78:684-90.
68. Maki T. Cholelithiasis in the Japanese. Arch Surg 1961; 82:599-612. 69.
69. Kim MH, Lim BC, Myung SJ, Lee SK, Ohrr HC, Kim YT, et al. Epidemiological study on Korean gallstone disease: a nationwide cooperative study. Dig Dis Sci 1999;44: 1674-83.
70. Zhu X, Zhang S, Huang Z. [The trend of the gallstone disease in China over the past decade]. Zhonghua Wai Ke Za Zhi 1995;33:652-8.
71. Chang MC, Kim KW, Kim SW, Yun YB, Park YH. Clinical and epidemiological analysis of 15-year experience of 2759 patients with gallstone. Korean J Gastroenterol 1998;31:100-6.
72. Marschall HU, Einarsson C. Gallstone disease. J Intern Med 2007;261:529-42.
73. Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, et al. Gallstones: genetics versus environment. Ann Surg 2002;235:842-9.
74. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 1996;26:343-52.
75. Chijiiwa K, Hirota I, Noshiro H. High vesicular cholesterol and protein in bile are associated with formation of cholesterol but not pigment gallstones. Dig Dis Sci 1993; 38:161-6.
76. Dowling RH. Review: pathogenesis of gallstones. Aliment Pharmacol Ther 2000;14(Suppl 2):39-47.
77. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006;20:981-96.
78. Bertolotti M, Gabbi C, Anzivino C, Crestani M, Mitro N, Del Puppo M, et al. Age-related changes in bile acid synthesis and hepatic nuclear receptor expression. Eur J Clin Invest 2007;37:501-8.
79. Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985;313:277-82.
80. Odom FC, Oliver BB, Kline M, Rogers W. Gallbladder disease in patients 20 years of age and under. South Med J 1976;69:1299-300.
81. Andrassy RJ, Treadwell TA, Ratner IA, Buckley CJ. Gallbladder disease in children and adolescents. Am J Surg 1976;132:19-21.
82. Calabrese C, Pearlman DM. Gallbladder disease below the age of 21 years. Surgery 1971;70:413-5.
83. Wesdorp I, Bosman D, de Graaff A, Aronson D, van der Blij F, Taminiau J. Clinical presentations and predisposing factors of cholelithiasis and sludge in children. J Pediatr Gastroenterol Nutr 2000;31:411-7.
84. Sanders G, Kingsnorth AN. Gallstones. Br Med J 2007; 335:295-9.
85. Cavallini A, Messa C, Mangini V, Argese V, Misciagna G, Giorgio I. Serum and bile lipids in young women with radiolucent gallstones. Am J Gastroenterol 1987;82: 1279-82.
86. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991;20:1-19.
87. Kameda H, Ishihara F, Shibata K, Tsukie E. Clinical and nutritional study on gallstone disease in Japan. Jpn J Med 1984;23:109-13.
88. Bernstein RA, Werner LH, Rimm AA. Relationship ofgall- bladder disease to parity, obesity, and age. Health Serv Rep 1973;88:925-36.
89. Jorgensen T. Gall stones in a Danish population: fertility period, pregnancies, and exogenous female sex hormones. Gut 1988;29:433-9.
90. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology 1988;8:907-13.
91. Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, et al. Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol 1996;8:585-93.
92. Braverman DZ, Johnson ML, Kern F Jr. Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 1980;302:362-4.
93. Stauffer RA, Adams A, Wygal J, Lavery JP. Gallbladder disease in pregnancy. Am J Obstet Gynecol 1982;144: 661-4.
94. Scragg RK, McMichael AJ, Seamark RF. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease - a case-control study. Br Med J (Clin Res Ed) 1984;288:1795-9.
95. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 1989;84:811-6.
96. Angelin B, Olivecrona H, Reihner E, Rudling M, Stahl- berg D, Eriksson M, et al. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology 1992; 103:1657-63.
97. Honore LH. Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study. J Reprod Med 1980;25:187-90.
98. Petitti DB, Sidney S, Perlman JA. Increased risk of cho- lecystectomy in users of supplemental estrogen. Gas- troenterology 1988;94:91-5.
99. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997;26: 809-18.
100. Angelico F, Del Ben M, Barbato A, Conti R, Urbinati G. Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Ital J Gastroenterol Hepatol 1997;29:249-54.
101. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-40.
102. Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg 1985;149:551-7.
103. Jorgensen T. Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut 1989;30:528-34.
104. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med 1978;299:1221-7.
105. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obes Res 1998;6(Suppl 2):51S-209S.
106. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, et al. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 1997;25:787-90.
107. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004;80:38-44.
108. Heaton KW, Braddon FEM, Emmett PM, Mountford RA, Hughes AP, Bolton CH, et al. Why do men get gallstones? Roles of abdominal fat and hyperinsulinemia. Eur J Gastroenterol Hepatol 1991;3:745-51.
109. Hartz AJ, Rupley DC, Rimm AA. The association ofgirth measurements with disease in 32,856 women. Am J Epidemiol 1984;119:71-80.
110. Haffner SM, Diehl AK, Mitchell BD, Stern MP, Hazuda HP. Increased prevalence of clinical gallbladder disease in subjects with non-insulin- dependent diabetes mellitus. Am J Epidemiol 1990;132:327-35.
111. Shaw SJ, Hajnal F, Lebovitz Y, Ralls P, Bauer M, Valen- zuela J, et al. Gallbladder dysfunction in diabetes mellitus. Dig Dis Sci 1993;38:490-6.
112. Kono S, Shinchi K, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, et al. Gallstone disease among Japanese men in relation to obesity, glucose intolerance, exercise, alcohol use, and smoking. Scand J Gastroenterol 1995;30:372-6.
113. Gielkens HA, Lam WF, Coenraad M, Frolich M, van Oostayen JA, Lamers CB, et al. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998;28:595-602.
114. Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med 1977; 296:1365-71.
115. Hoogerwerf WA, Soloway RD. Gallstones. Curr Opin Gastroenterol 2000;16:450-3.
116. de Leon MP, Ferenderes R, Carulli N. Bile lipid composition and bile acid pool size in diabetes. Am J Dig Dis 1978;23:710-6.
117. Sweeney G, Klip A. Mechanisms and consequences of Na +, K + -pump regulation by insulin and leptin. Cell Mol Biol (Noisy-le-grand) 2001;47:363-72.
118. Misciagna G, Guerra V, Di Leo A, Correale M, Trevisan M. Insulin and gall stones: a population case control study in southern Italy. Gut 2000;47:144-7.
119. Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci 2008;23:644-50.
120. Janzon L, Aspelin P, Eriksson S, Hildell J, Trell E, Ost- berg H. Ultrasonographic screening for gallstone disease in middle-aged women. Detection rate, symptoms, and biochemical features. Scand J Gastroenterol 1985;20:706-10.
121. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term intake of trans-fatty acids and risk of gallstone disease in men. Arch Intern Med 2005;165: 1011-5.
122. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990;99:843-9.
123. Sturdevant RA, Pearce ML, Dayton S. Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. N Engl J Med 1973;288:24-7.
124. Lee DW, Gilmore CJ, Bonorris G, Cohen H, Marks JW, Cho-Sue M, et al. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects. Am J Clin Nutr 1985;42:414-20.
125. Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gall stone disease: a case-control study. Br Med J (Clin Res Ed) 1984;288:1113-9.
126. Ferezou J, Beau P, Parquet M, Champarnaud G, Lutton C, Matuchansky C. Cholesterol and bile acid biodyna- mics after total small bowel resection and bile diversion in humans. Gastroenterology 1993;104:1786-95.
127. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med 2004;141:514-22.
128. Caroli-Bosc FX, Deveau C, Peten EP, Delabre B,Zanaldi H, Hebuterne X, et al. Cholelithiasis and dietary riskfac- tors: an epidemiologic investigation in Vidauban, Southeast France. General Practitioner's Group of Vidauban. Dig Dis Sci 1998;43:2131-7.
129. Jorgensen T, Jorgensen LM. Gallstones and diet in a Danish population. Scand J Gastroenterol 1989;24:821- 6.
130. Diehl AK, Haffner SM, Knapp JA, Hazuda HP, Stern MP. Dietary intake and the prevalence of gallbladder disease in Mexican Americans. Gastroenterology 1989; 97:1527-33.
131. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, et al. Diet, physical activity, and gallstones - a population-based, case-control study in southern Italy. Am J Clin Nutr 1999;69:120-6.
132. Kritchevsky D, Klurfeld DM. Gallstone formation in hamsters: effect of varying animal and vegetable protein levels. Am J Clin Nutr 1983;37:802-4.
133. Kritchevsky D, Klurfeld DM. Influence of vegetable protein on gallstone formation in hamsters. Am J Clin Nutr 1979;32:2174-6.
134. Mendez-Sanchez N, Zamora-Valdes D, Chavez-Tapia NC, Uribe M. Role of diet in cholesterol gallstone formation. Clin Chim Acta 2007;376:1-8.
135. Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile - three interrelated factors. Gut 1986;27:550-8.
136. Marcus SN, Heaton KW. Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycho- lic acid metabolism and the composition of bile. Gut 1986;27:893-900.
137. Tandon RK, Saraya A, Paul S, Kapur BM. Dietary habits of gallstone patients in Northern India. J Clin Gastroenterol 1996;22:23-7.
138. Ortega RM, Fernandez-Azuela M, Encinas-Sotillos A, Andres P, Lopez-Sobaler AM. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr 1997;16:88-95.
139. Marchesini G, Forlani G. NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 2002;35:497-9.
140. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Spei- zer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989;321:563-9.
141. Sichieri R, Everhart JE, Roth H. A prospective study of hospitalization with gallstone disease among women: role of dietary factors, fasting period, and dieting. Am J Public Health 1991;81:880-4.
142. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Prevalence of gallstone disease in relation to smoking, alcohol use, obesity, and glucose tolerance: a study of self-defense officials in Japan. Am J Epidemiol 1992; 136:787-94.
143. Leitzmann MF, Willett WC, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. J Am Med Assoc 1999;281:2106-12.
144. Leitzmann MF, Giovannucci EL, Stampfer MJ, Spiegel- man D, Colditz GA, Willett WC, et al. Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. Alcohol Clin Exp Res 1999;23:835-41.
145. La Vecchia C, Decarli A, Ferraroni M, Negri E. Alcohol drinking and prevalence of self-reported gallstone disease in the 1983 Italian National Health Survey. Epidemiology 1994;5:533-6.
146. Simon JA, Hudes ES. Serum ascorbic acid and other correlates of gallbladder disease among US adults. Am J Public Health 1998;88:1208-12.
147. Moerman CJ, Smeets FW, Kromhout D. Dietary riskfac- tors for clinically diagnosed gallstones in middle-aged men. A 25-year follow-up study (the Zutphen Study). Ann Epidemiol 1994;4:248-54.
148. Nestel PJ, Simons LA, Homma Y. Effects of ethanol on bile acid and cholesterol metabolism. Am J Clin Nutr 1976;29:1007-15.
149. Fornari F, Imberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, et al. Incidence of gallstones in a population of patients with cirrhosis. J Hepatol 1994; 20:797-801.
150. La Vecchia C, Negri E, D'Avanzo B, Franceschi S, Boyle P. Risk factors for gallstone disease requiring surgery. Int J Epidemiol 1991;20:209-15.
151. Douglas BR, Jansen JB, Tham RT, Lamers CB. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. Am J Clin Nutr 1990;52:553-6.
152. Keiner F. [The effect of coffee on gallbladder contractions]. Med Welt 1965;34:1907-12.
153. Rao SS, Welcher K, Zimmerman B, Stumbo P. Is coffee a colonic stimulant? Eur J Gastroenterol Hepatol 1998; 10:113-8.
154. Ishizuk H, Eguchi H, Oda T, Ogawa S, Nakagawa K, Honjo S, et al. Relation of coffee, green tea, and caffeine intake to gallstone disease in middle-aged Japanese men. Eur J Epidemiol 2003;18:401-5.
155. Kratzer W, Kachele V, Mason RA, Muche R, Hay B, Wiesneth M, et al. Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition. The Ulm Gallstone Study. Scand J Gastroenterol 1997; 32:953-8.
156. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men. Am J Gastroenterol 2008;103:375-82.
157. Guerrero-Romero F, Rodriguez-Moran M. Hypomagne- semia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complicat 2000;14:272-6.
158. Gueux E, Azais-Braesco V, Bussiere L, Grolier P, Mazur A, Rayssiguier Y. Effect of magnesium deficiency on triacylglycerol-rich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. Br J Nutr 1995;74:849-56.
159. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Heme and non-heme iron consumption and risk ofgall- stone disease in men. Am J Clin Nutr 2007;85:518-22.
160. Fields M, Lewis CG. Level of dietary iron, not type of dietary fat, is hyperlipidemic in copper-deficient rats. J Am Coll Nutr 1999;18:353-7.
161. Eder MI, Miquel JF, Jongst D, Paumgartner G, von Rit- ter C. Reactive oxygen metabolites promote cholesterol crystal formation in model bile: role of lipid peroxida- tion. Free Radic Biol Med 1996;20:743-9.
162. Whorwell PJ, Hawkins R, Dewbury K, Wright R. Ultrasound survey of gallstones and other hepatobiliary disorders in patients with Crohn's disease. Dig Dis Sci 1984;29:930-3.
163. Fraquelli M, Losco A, Visentin S, Cesana BM, Pometta R, Colli A, et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med 2001;161:2201-4.
164. Baker AL, Kaplan MM, Norton RA, Patterson JF. Gallstones in inflammatory bowel disease. Am J Dig Dis 1974;19:109-12.
165. Cohen S, Kpplan M, Gottlieb L, Patterson J. Liver disease and gallstones in regional enteritis. Gastroenter- ology 1971;60:237-45.
166. Lapidus A, Bangstad M, Astrom M, Muhrbeck O. The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease. Am J Gastroenterol 1999;94:1261-6.
167. Hutchinson R, Tyrrell PN, Kumar D, Dunn JA, Li JK, Allan RN. Pathogenesis of gall stones in Crohn's disease: an alternative explanation. Gut 1994;35:94-7.
168. Dowling RH, Bell GD, White J. Lithogenic bile in patients with ileal dysfunction. Gut 1972;13:415-20.
169. Schmidt JH, Hocking MP, Rout WR, Woodward ER. The case for prophylactic cholecystectomy concomitant with gastric restriction for morbid obesity. Am Surg 1988;54:269-72.
170. Deitel M, Petrov I. Incidence of symptomatic gallstones after bariatric operations. Surg Gynecol Obstet 1987; 164:549-52.
171. Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci 1992;37:912-8.
172. Shiffman ML, Sugerman HJ, Kellum JM, Moore EW. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterol- ogy 1992;103:214-21.
173. Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW. Gallstone formation after rapid weightloss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991;86:1000-5.
174. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, et al. Effects of urso- deoxycholic acid and aspirin on the formation of litho- genic bile and gallstones during loss of weight. N Engl J Med 1988;319:1567-72.
175. Gebhard RL, Prigge WF, Ansel HJ, Schlasner L, Ketover SR, Sande D, et al. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 1996;24:544-8.
176. Acalovschi M, Badea R, Pascu M. Incidence of gallstones in liver cirrhosis. Am J Gastroenterol 1991; 86:1179-81.
177. Zhang Y, Liu D, Ma Q, Dang C, Wei W, Chen W. Factors influencing the prevalence of gallstones in liver cirrhosis. J Gastroenterol Hepatol 2006;21:1455-8.
178. Conte D, Barisani D, Mandelli C, Bodini P, Borzio M, Pistoso S, et al. Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol 1991;86:1629-32.
179. Sheen IS, Liaw YF. The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: a prospective study. Hepatology 1989;9:538-40.
180. Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, et al. Cirrhosis of the liver. A risk factor for development of cholelithiasis in males. Dig Dis Sci 1990;35:1403-8.
181. Buchner AM, Sonnenberg A. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. Am J Gastroenterol 2002;97:905-9.
182. Schwesinger WH, Kurtin WE, Levine BA, Page CP. Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation. Ann Surg 1985;201:319-22.
183. Diehl AK, Schwesinger WH, Holleman DR Jr, Chapman JB, Kurtin WE. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones. Am J Gastroenterol 1995;90:967-72.
184. Vlahcevic ZR, Yoshida T, Juttijudata P, Bell CC Jr, Swell L. Bile acid metabolism in cirrhosis. 3. Biliary lipid secretion in patients with cirrhosis and its relevance to gallstone formation. Gastroenterology 1973;64:298-303.
185. Alvaro D, Angelico M, Gandin C, Ginanni Corradini S, Capocaccia L. Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis. J Hepatol 1990;10:228-34.
186. Attili AF, Casale R, Di Lauro G, Festuccia V, Natali L, Pasqualetti P. [Assessment of gallbladder motility in patients with alcoholic hepatic cirrhosis after a fatty meal. A real-time ultrasonography study]. Minerva Gastroenterol Dietol 1992;38:45-8.
187. Acalovschi M, Dumitrascu DL, Csakany I. Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis - a simultaneous sonographic study. Gut 1997;40:412-7.
188. Li CP, Hwang SJ, Lee FY, Chang FY, Lin HC, Lu RH, et al. Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. Dig Dis Sci 2000;45:1109-14.
189. Schwesinger WH, Kurtin WE. Changes in serum and bile bilirubin induced by acute hemolysis. J Surg Res 1983;35:520-4.
190. Stroffolini T, Sagnelli E, Mele A, Cottone C, Almasio PL. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. J Viral Hepat 2007;14:618-23.
191. Chang TS, Lo SK, Shyr HY, Fang JT, Lee WC, Tai DI, et al. Hepatitis C
192. Bini EJ, McGready J. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States. Hepatology 2005;41:1029-36.
193. Shoda J, Kano M, Asano T, Irimura T, Ueda T, Iwasaki R, et al. Secretory low-molecular-weight phospholi- pases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors ofchronic proliferative cholangitis. Hepatology 1999;29:1026-36.
194. Thomas LA, Veysey MJ, Bathgate T, King A, French G, Smeeton NC, et al. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cho- lesterol cholelithiasis. Gastroenterology 2000;119:806-15.
195. Veysey MJ, Thomas LA, Mallet AI, Jenkins PJ, Besser GM, Wass JA, et al. Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut 1999;44:675-81.
196. Hussaini SH, Pereira SP, Veysey MJ, Kennedy C, Jenkins P, Murphy GM, et al. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones. Gut 1996;38: 775-83.
197. Apstein MD, Dalecki-Chipperfield K. Spinal cord injury is a risk factor for gallstone disease. Gastroenterology 1987;92:966-8.
198. Moser AJ, Giurgiu DI, Morgenstern KE, Abedin ZR, Roslyn JJ, Abedin MZ. Octreotide stimulates Ca++ secretion by the gallbladder: a risk factor for gallstones. Surgery 1999;125:509-13.
199. Bolondi L, Gaiani S, Testa S, Labo G. Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery. Gut 1985;26:734-8.
200. Messing B, Bories C, Kunstlinger F, Bernier JJ. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology1983;84:1012-9.
201. Lammert F, Carey MC, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastro- enterology 2001;120:221-38.
202. Jackson CE, Gay BC. Inheritance of gall-bladder disease. Surgery 1959;46:853-7.
203. Gilat T, Feldman C, Halpern Z, Dan M, Bar-Meir S. An increased familial frequency of gallstones. Gastroen- terology 1983;84:242-6.
204. Sarin SK, Negi VS, Dewan R, Sasan S, Saraya A. High familial prevalence of gallstones in the first-degree relatives of gallstone patients. Hepatology 1995;22:138- 41.
205. Jorgensen T. Gallstones in a Danish population: familial occurrence and social factors. J Biosoc Sci 1988; 20:111-20.
206. Lammert F, Miquel JF. Gallstone disease: from genes to evidence-based therapy. J Hepatol 2008;48(Suppl 1): S124-35.
207. Danzinger RG, Gordon H, Schoenfield LJ, Thistle JL. Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc 1972;47:762-6.
208. Harvald B, Hauge M. A catamnestic investigation of Danish twins; a preliminary report. Dan Med Bull 1956; 3:150-8.
209. Antero Kesaniemi Y, Koskenvuo M, Vuoristo M, Miet- tinen TA. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989;30:1750-6.
210. Duggirala R, Mitchell BD, Blangero J, Stern MP. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol 1999;16:191-204.
211. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lich- tenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005; 41:1138-43.
212. Cunningham JA, Hardenbergh FE. Comparative incidence of choletithiasis in the Negro and white races; a study of 6185 autopsies. AMA Arch Intern Med 1956;97:68-72.
213. Sichieri R, Everhart JE, Roth HP. Low incidence of hospitalization with gallbladder disease among blacks in the United States. Am J Epidemiol 1990;131:826-35.
214. Davion T, Tossou H, Delamarre J, Capron JP. Racial differences in gallbladder motor function. Lancet 1989; 1:724-5.
215. Lammert F, Matern S. The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:163-70.
216. Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003;125:452-9.
217. Buch S, Schafmayer C, Volzke H, Becker C, Franke A, von Eller-Eberstein H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007;39:995-9.
218. Kosters A, Jirsa M, Groen AK. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta 2003;1637:1-19.
219. Bertomeu A, Ros E, Zambon D, Vela M, Perez-Ayuso RM, Targarona E, et al. Apolipoprotein E polymorphism and gallstones. Gastroenterology 1996;111:1603-10.
220. Mella JG, Schirin-Sokhan R, Rigotti A, Pimentel F, Vil- larroel L, Wasmuth HE, et al. Genetic evidence that apo- lipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations. J Lipid Res 2007;48:1378-85.
221. Wasmuth HE, Keppeler H, Herrmann U, Schirin-Sokhan R, Barker M, Lammert F. Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis. Hepatology 2006;43:738-41.
222. Vasavda N, Menzel S, Kondaveeti S, Maytham E, Awogbade M, Bannister S, et al. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 2007;138:263-70.
223. Broulik PD, Haas T, Adamek S. Analysis of 645 patients with primary hyperparathyroidism with special references to cholelithiasis. Intern Med 2005;44:917-21.
224. Christensson T, Einarsson K. Cholelithiasis in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening. Gut 1977;18:543-6.
225. Tamary H, Aviner S, Freud E, Miskin H, Krasnov T, Schwarz M, et al. High incidence of early cholelithiasis detected by ultrasonography in children and young adults with hereditary spherocytosis. J Pediatr Hematol Oncol 2003;25:952-4.
226. Origa R, Galanello R, Perseu L, Tavazzi D, Domenica Cappellini M, Terenzani L, et al. Cholelithiasis in thal- assemia major. Eur J Haematol 2009;82:22-5.
227. Aughton DJ, Gibson P, Cacciarelli A. Cholelithiasis in infants with Down syndrome. Three cases and literature review. Clin Pediatr (Phila) 1992;31:650-2.
228. Tasdemir HA, Cetinkaya MC, Polat C, Belet U, Kalayci AG, Akbas S. Gallbladder motility in children with Down syndrome. J Pediatr Gastroenterol Nutr 2004; 39:187-91.
229. Chen MH, Chen SJ. Cholelithiasis in Down syndrome. Acta Paediatr Taiwan 2004;45:269-71.
230. Llerena JC Jr, Boy R, Barbosa Neto J, Vargas F, Fon- tana C, de Almeida JC, et al. Abdominal ultrasound scan in Down syndrome patients: high frequency of nonsymptomatic biliary tract disease. Am J Med Genet 1993;46:612.
231. Toscano E, Trivellini V, Andria G. Cholelithiasis in Down's syndrome. Arch Dis Child 2001;85:242-3.
232. Palasciano G, Portincasa P, Vinciguerra V, Velardi A, Tardi S, Baldassarre G, et al. Gallstone prevalence and gallbladder volume in children and adolescents: an epi- demiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol 1989;84: 1378-82.
233. Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH. Classification and nomenclature of gallstones revisited. Yonsei Med J 2003;44:561-70.